A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 Jan 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Lewy body disease
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 28 Dec 2017 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 28 Dec 2017 Planned primary completion date changed from 1 Feb 2018 to 1 May 2018.
- 28 Dec 2017 Status changed from recruiting to active, no longer recruiting.